1 Min Read
June 27 (Reuters) - Bayer AG : * Says aflibercept (Eylea) receives positive CHMP opinion for the treatment of visual impairment due to diabetic macular edema in EU
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.